MULTIPLE MYELOMA
Vysis LSI D5S23, D5S721/CEP 9/CEP 15 FISH Probe Kit
For more information, contact Abbott.
For more information, contact Abbott.
| PRODUCT NAME | UNIT SIZE | ORDER NUMBER | GTIN |
|---|
The Vysis D5S23, D5S721/CEP 9/CEP 15 FISH Probe Kit is intended to detect the copy number of the D5S23,D5S721, CEP 9 and CEP 15 probe targets located at 5p15.2, 9p11.1-q11.1 and 15p11.1-q11.1, respectively, using the fluorescence in situ hybridization (FISH) technique.
The approximately 561 kb (chr5:9450109-10011407; March 2006 assembly) SpectrumGreen probe is located at chromosome 5p15.2 The SpectrumAqua probe contains alpha satellite sequences and is specific to chromosome 9p11.1-q11.1. The SpectrumOrange probe contains D15Z4 alpha satellite sequences and is specific to chromosome 15p11.1-q11.1.
In an abnormal cell containing hyperdiploidy of either chromosome 5, chromosome 9 or chromosome 15, greater than two signals will be observed for the respective chromosomes.
In a normal cell that lacks hyperdiploidy of chromosome 5, chromosome 9 and chromosome15, a two green, two aqua and two orange signal pattern will be observed reflecting the two copies of each chromosome.
Normal Hybridization: An interphase cell hybridized with the LSI D5S23, D5S721/ CEP 9/CEP 15 Probe. The cell shows the two green (LSI D5S23, D5S721), two aqua (CEP 9) and two orange (CEP 15) signal patterns.
Abnormal Hybridization: An interphase cell hybridized with the LSI D5S23, D5S721/ CEP 9/CEP 15 Probe. The cell in this image shows a two green (LSI D5S23, D5S721), three aqua (CEP 9) and three orange (CEP 15) signal patterns.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.